One piece of a planned $2.1 billion expansion of the life sciences district Cortex has fallen into place.
The life sciences district known as Cortex has gotten initial approval for the first phase of its $2.1 billion expansion plan.
The city's Tax Increment Financing commission voted today to authorize about $35 million in incentives for the first phase, which totals about $160 million.
The phase includes new office and laboratory space, a new Shriners' Hospital, and a streetscape known as Cortex Commons. Here's how it breaks down:
Tomorrow is the one year anniversary of Occupy Wall Street and local activist groups plan to mark the occasion by protesting biotechnology giant Monsanto.
Barbara Chicherio is with the Gateway Green Alliance, which opposes genetically modified organisms developed by St. Louis based Monsanto and other biotech companies.
She said tomorrow's protests will represent a shift within the Occupy movement to focus on specific issues.
Monsanto is leading the fight to block a California ballot initiative that would require labeling of food with genetically modified ingredients.
People are sometimes used as test subjects in scientific research – from clinical trials, to studies on the toxicity of pesticides.
The federal government is currently revising the regulation designed to protect human research subjects from harm.
Washington University law professor Rebecca Dresser wrote an article published in the journal Science, talking about some changes she’d like to see made. She spoke with St. Louis Public Radio's Véronique LaCapra.
St. Louis Public Radio is a service of the University of Missouri-St. Louis.